ask="3.45"
ask_size="500"
average_daily_volume="227832"
bid="2.40"
bid_size="1200"
book_value="5.66"
change="+0.05"
change_from_200_day_moving_average="-0.52"
change_from_50_day_moving_average="-0.08"
change_from_52_week_high="-3.36"
change_From_52_week_low="0.21"
change_in_percent="+1.72%"
close="2.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.27"
ebitda="-47.17M"
eps_estimate_current_year="-2.41"
eps_estimate_next_quarter="-0.31"
eps_estimate_next_year="-1.28"
ex_dividend_date="N/A"
float_shares="28534000"
high="2.97"
high_52_weeks="6.31"
last_trade_date="2/1/2017"
last_trade_price="2.95"
last_trade_size="5761"
last_trade_time="4:00pm"
low="2.85"
low_52_weeks="2.74"
market_capitalization="123.07M"
moving_average_200_day="3.47"
moving_average_50_day="3.03"
name="Adverum Biotechnologies
Inc."
notes="N/A"
one_year_target_price="8.67"
open="2.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-15.00%"
percent_change_from_50_day_moving_average="-2.80%"
percent_change_from_52_week_high="-53.25%"
percent_change_from_52_week_low="+7.66%"
previous_close="2.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.51"
price_per_sales="62.78"
revenue="1.93M"
shares_outstanding="41718000"
short_ratio="1.20"
stock_exchange="NGM"
symbol="ADVM"
volume="285103"
weeks_range_52="2.74 - 6.31"
